Morningstar

GE HealthCare Technologies Inc Common Stock GEHC

Morningstar Rating
Unlock
Stock XNAS Rating as of
$64.29 +0.31 (0.48%)
View Full Chart
As of Delayed Price Post-Trading: $64.02 −0.27

Company Report

View Archive

Medical Imaging Giant GE HealthCare Is Finding Its Footing to Stand Alone

Jay Lee

Wide-moat GE HealthCare is a top-three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is positioned to benefit from long-term healthcare trends, including aging populations, the growing demand for early detection and monitoring of cancer and other diseases, and increasing utilization of minimally invasive and noninvasive procedures.

Read Analysis

Price vs Fair Value

View History
GEHC is trading at a LOCK|SQ?Yg@t premium.
Price
$63.98
Fair Value
^pj
Uncertainty
LOCK|ml&v<
1-Star Price
LOCK|b.D
5-Star Price
LOCK|.zQ
Economic Moat
LOCK|#ld
Capital Allocation
LOCK|wKpg>#

Bulls Say, Bears Say

Bulls

Now that it has been spun off, GEHC is able to focus on R&D and operational efficiency without competing internally with GE’s other business lines.

Bears

GEHC does not have a long record of operating as a stand-alone company.

Show More

News

View All

Articles & Videos

Trading Information

Previous Close Price
$63.98
Day Range
$63.96–64.99
52-Week Range
$58.75–89.77
Bid/Ask
$63.90 / $65.00
Shares Outstanding
451.69M
Market Cap
$29.04B
Volume/Avg
3M / 4M

Key Statistics

Price/Earnings (Normalized)
13.82
Price/Sales
1.37
Dividend Yield (Trailing)
0.22%
Dividend Yield (Forward)
0.25%
Dividend Payment Schedule
Feb, May, Aug, Nov
Total Yield
1.60%

Company Profile

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Value
Total Number of Employees
54,000
Website
https://www.gehealthcare.com

Competitors

Valuation

View More
Metric
GEHC
SHL
PHIA
Price/Earnings (Normalized)
 13.8217.3711.65
Price/Book Value
 2.632.201.79
Price/Sales
 1.371.821.16
Price/Cash Flow
 12.3413.188.11
Price/Earnings
GEHC
SHL
PHIA

Financial Strength

Metric
GEHC
SHL
PHIA
Quick Ratio
 0.840.740.73
Current Ratio
 1.261.161.26
Interest Coverage
 7.157.885.51
Quick Ratio
GEHC
SHL
PHIA

Profitability

Metric
GEHC
SHL
PHIA
Return on Assets (Normalized)
 5.78%5.00%6.09%
Return on Equity (Normalized)
 20.45%12.25%14.83%
Return on Invested Capital (Normalized)
 11.38%12.99%9.41%
Return on Assets
GEHC
SHL
PHIA

Medical Devices Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|$cZ<KTKLOCK|^$YH$167B
 Medtronic PLC
MDT
LOCK|>y!Ww$LOCK|jZVG$111B
 Stryker Corp
SYK
LOCK|r<NnrBK<LOCK|Kq$105B
 Boston Scientific Corp
BSX
LOCK|$Ybw!v%LOCK|p^T&L$63B
 Edwards Lifesciences Corp
EW
LOCK|?JZD?$srLOCK|Rpj>S$49B
 DexCom Inc
DXCM
LOCK|Wg$!b$T&LOCK|l?!n!$33B
 Koninklijke Philips NV ADR
PHG
LOCK|&%>LOCK|h@J$23B
 Steris PLC
STE
LOCK|^&&^r<rLOCK|mSZ&F$20B
 Zimmer Biomet Holdings Inc
ZBH
LOCK|Xq<?<r>LOCK|f?^$17B

Sponsor Center